These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11169537)

  • 1. Kinetics of finite dose absorption through skin 1. Vanillylnonanamide.
    Kasting GB
    J Pharm Sci; 2001 Feb; 90(2):202-12. PubMed ID: 11169537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous absorption of vanilloids: in vivo and in vitro studies.
    Kasting GB; Francis WR; Bowman LA; Kinnett GO
    J Pharm Sci; 1997 Jan; 86(1):142-6. PubMed ID: 9002474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of finite dose absorption through skin 2: volatile compounds.
    Kasting GB; Miller MA
    J Pharm Sci; 2006 Feb; 95(2):268-80. PubMed ID: 16381026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simplified approach for estimating skin permeation parameters from in vitro finite dose absorption studies.
    Lehman PA
    J Pharm Sci; 2014 Dec; 103(12):4048-4057. PubMed ID: 25324199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of solvent on percutaneous absorption of nonvolatile lipophilic solute.
    Intarakumhaeng R; Li SK
    Int J Pharm; 2014 Dec; 476(1-2):266-76. PubMed ID: 25261711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption and evaporation of N,N-diethyl-m-toluamide from human skin in vitro.
    Santhanam A; Miller MA; Kasting GB
    Toxicol Appl Pharmacol; 2005 Apr; 204(1):81-90. PubMed ID: 15781296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terpene penetration enhancers in propylene glycol/water co-solvent systems: effectiveness and mechanism of action.
    Yamane MA; Williams AC; Barry BW
    J Pharm Pharmacol; 1995 Dec; 47(12A):978-89. PubMed ID: 8932680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption of ethanol, acetone, benzene and 1,2-dichloroethane through human skin in vitro: a test of diffusion model predictions.
    Gajjar RM; Kasting GB
    Toxicol Appl Pharmacol; 2014 Nov; 281(1):109-17. PubMed ID: 25283951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maximum transepidermal flux for similar size phenolic compounds is enhanced by solvent uptake into the skin.
    Zhang Q; Li P; Roberts MS
    J Control Release; 2011 Aug; 154(1):50-7. PubMed ID: 21549777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion modeling of percutaneous absorption kinetics: 2. Finite vehicle volume and solvent deposited solids.
    Anissimov YG; Roberts MS
    J Pharm Sci; 2001 Apr; 90(4):504-20. PubMed ID: 11170040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion modelling of percutaneous absorption kinetics: 4. Effects of a slow equilibration process within stratum corneum on absorption and desorption kinetics.
    Anissimov YG; Roberts MS
    J Pharm Sci; 2009 Feb; 98(2):772-81. PubMed ID: 18543296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental factors affecting in vitro absorption of six model compounds across porcine skin.
    Karadzovska D; Brooks JD; Riviere JE
    Toxicol In Vitro; 2012 Oct; 26(7):1191-8. PubMed ID: 22750544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A method to assess dermal absorption dynamics of chemical warfare agents: Finite doses of volatile compounds.
    Lear K; Simon L
    J Occup Environ Hyg; 2022; 19(10-11):603-614. PubMed ID: 35969798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compartmental modeling of skin absorption and desorption kinetics: Donor solvent evaporation, variable diffusion/partition coefficients, and slow equilibration process within stratum corneum.
    Amarah AA; Hadgraft J; Roberts MS; Anissimov YG
    Int J Pharm; 2022 Jul; 623():121902. PubMed ID: 35691525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A physiologically based pharmacokinetic model of organophosphate dermal absorption.
    van der Merwe D; Brooks JD; Gehring R; Baynes RE; Monteiro-Riviere NA; Riviere JE
    Toxicol Sci; 2006 Jan; 89(1):188-204. PubMed ID: 16221965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous absorption and distribution of organophosphates (chlorpyrifos and dichlorvos) following dermal exposure and decontamination scenarios using in vitro human skin model.
    Moore CA; Wilkinson SC; Blain PG; Dunn M; Aust GA; Williams FM
    Toxicol Lett; 2014 Aug; 229(1):66-72. PubMed ID: 24910989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A compartment model to predict in vitro finite dose absorption of chemicals by human skin.
    Fisher HA; Evans MV; Bunge AL; Hubal EAC; Vallero DA
    Chemosphere; 2024 Feb; 349():140689. PubMed ID: 37963497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of steady-state skin permeabilities of polar and nonpolar permeants across excised pig skin based on measurements of transient diffusion: characterization of hydration effects on the skin porous pathway.
    Tang H; Blankschtein D; Langer R
    J Pharm Sci; 2002 Aug; 91(8):1891-907. PubMed ID: 12115816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of experimental conditions on absorption of glycol ethers through human skin in vitro.
    Wilkinson SC; Williams FM
    Int Arch Occup Environ Health; 2002 Oct; 75(8):519-27. PubMed ID: 12373313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the absorption kinetics following dermal exposure to large doses of volatile organic compounds.
    Simon L
    Math Biosci; 2022 Sep; 351():108889. PubMed ID: 35988791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.